Premium
Rise of Defibrillation Energy Requirement Under Carvedilol Therapy
Author(s) -
MELICHERCIK JURAJ,
GOEPFRICH MICHAEL,
BREIDENBACH THOMAS,
VON HODENBERG EBERHARD
Publication year - 2001
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1046/j.1460-9592.2001.01417.x
Subject(s) - medicine , carvedilol , defibrillation , concomitant , cardiology , blocking (statistics) , energy requirement , anesthesia , heart failure , psychotherapist , psychology , regression , statistics , mathematics
MELICHERCIK, et al. : Rise of Defibrillation Energy Requirement Under Carvedilol Therapy. Carvedilol, a nonselective β1‐, β2‐adrenoreceptor blocking agent with α1‐adrenoreceptor blocking activity, is often prescribed as an adjunctive pharmacological therapy in patients who received an ICD. Despite the new ICD technology, concomitant antiarrhythmic therapy still represents the most important concern in patients with an ICD. As illustrated by this case, carvedilol may also increase the energy requirement for internal defibrillation.